Our leadership team combines 70 years of expertise in blockchain, information technology, pharma, medtech and clinical research.
Thomas has been active in the biotech and medtech business for >30 years. He is currently the CEO of Altamira Therapeutics Ltd., a biomedical company developing therapeutics for indications in oncology, neurotology, allergology and infectiology. In this role, he designed and oversaw 14 clinical trials, ranging from Phase 1 to Phase 3. Prior to founding Altamira Therapeutics in 2003, he was the CEO of Disetronic Group, a fast-growing Swiss drug delivery company.
Dominik has acquired extensive experience in clinical research since 2004. First, he set up and managed clinical trials for biotech and medtech companies. In 2010 he founded credentis, a Swiss company developing novel products for dental and oral care treatments. As its CEO, he designed and oversaw credentis' clinical program. In 2020, credentis was successfully acquired by vVardis.
Dominik is currently Co-CSO of vVardis.
Frank is a serial entrepreneur who has been working for >30 years in information technology with a strong focus on the development and commercialization of software solutions spanning the complete clinical trial process. He started his career with Oracle as database consultant and later became responsible for clinical trial data management solutions with one of the Top 10 pharma companies.